Mitochondrial heterogeneity in diseases

L Chen, M Zhou, H Li, D Liu, P Liao, Y Zong… - … and Targeted Therapy, 2023 - nature.com
As key organelles involved in cellular metabolism, mitochondria frequently undergo
adaptive changes in morphology, components and functions in response to various …

Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship

A Karkucinska‐Wieckowska… - European journal of …, 2022 - Wiley Online Library
According to the 'multiple‐hit'hypothesis, several factors can act simultaneously in
nonalcoholic fatty liver disease (NAFLD) progression. Increased nitro‐oxidative (nitroso …

[HTML][HTML] Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis

MF Fondevila, U Fernandez, V Heras, T Parracho… - Journal of …, 2022 - Elsevier
Background & Aims The pathogenesis of liver fibrosis requires activation of hepatic stellate
cells (HSCs); once activated, HSCs lose intracellular fatty acids but the role of fatty acid …

Mitochondrial CPT1A: Insights into structure, function, and basis for drug development

K Liang - Frontiers in pharmacology, 2023 - frontiersin.org
Carnitine Palmitoyl-Transferase1A (CPT1A) is the rate-limiting enzyme in the fatty acid β-
oxidation, and its deficiency or abnormal regulation can result in diseases like metabolic …

Fructose impairs fat oxidation: Implications for the mechanism of western diet-induced NAFLD

MK Inci, SH Park, RN Helsley, SL Attia… - The Journal of nutritional …, 2023 - Elsevier
Increased fructose intake from sugar-sweetened beverages and highly processed sweets is
a well-recognized risk factor for the development of obesity and its complications. Fructose …

Precision medicine in fatty liver disease/non-alcoholic fatty liver disease

L Valenzuela-Vallejo, D Sanoudou… - Journal of Personalized …, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, and is
related to fatal and non-fatal liver, metabolic, and cardiovascular complications. Its non …

NADPH oxidases connecting fatty liver disease, insulin resistance and type 2 diabetes: Current knowledge and therapeutic outlook

A Nascè, K Gariani, FR Jornayvaz, I Szanto - Antioxidants, 2022 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD), characterized by ectopic fat accumulation in
hepatocytes, is closely linked to insulin resistance and is the most frequent complication of …

[HTML][HTML] Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas

H Souza-Tavares, CS Miranda… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The world is experiencing reflections of the intersection of two pandemics: Obesity and
coronavirus disease 2019. The prevalence of obesity has tripled since 1975 worldwide …

Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic

G Rao, X Peng, X Li, K An, H He, X Fu, S Li… - Frontiers in Medicine, 2023 - frontiersin.org
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly defined as non-
alcoholic fatty liver disease (NAFLD), is a disorder marked by the excessive deposition of …

[HTML][HTML] The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression

J Wang, H Xiang, Y Lu, T Wu, G Ji - American Journal of Cancer …, 2021 - ncbi.nlm.nih.gov
Cancer cells must maintain metabolic homeostasis under a wide range of conditions and
meet their own energy needs in order to survive and reproduce. In addition to glycolysis …